Global Prostate Cancer Diagnostics Market Professional Survey Report 2018
- QYR2636391
- 116 Pages
- July 2018
- Pharmaceuticals
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
The global average gross margin of Prostate Cancer Diagnostics is in the decreasing trend, from 73.4% in 2012 to 71.6% in 2016. With the situation of global economy and technology, gross margin will be in decreasing trend in the following five years.
The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2016 is about 44%.
Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Prostate Cancer Diagnostics market is valued at 11900 million US$ in 2017 and will reach 20300 million US$ by the end of 2025, growing at a CAGR of 6.9% during 2018-2025.
The major manufacturers covered in this report
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Tumor Biomarker Tests
Imaging
Biopsy
Other
By Application, the market can be split into
age < 55
age 55-75
age > 75
The study objectives of this report are:
To analyze and study the global Prostate Cancer Diagnostics capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Prostate Cancer Diagnostics manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Prostate Cancer Diagnostics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Prostate Cancer Diagnostics Manufacturers
Prostate Cancer Diagnostics Distributors/Traders/Wholesalers
Prostate Cancer Diagnostics Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Prostate Cancer Diagnostics market, by end-use.
Detailed analysis and profiles of additional market players.
Global Prostate Cancer Diagnostics Market Professional Survey Report 2018
1 Industry Overview of Prostate Cancer Diagnostics
1.1 Definition and Specifications of Prostate Cancer Diagnostics
1.1.1 Definition of Prostate Cancer Diagnostics
1.1.2 Specifications of Prostate Cancer Diagnostics
1.2 Classification of Prostate Cancer Diagnostics
1.2.1 Tumor Biomarker Tests
1.2.2 Imaging
1.2.3 Biopsy
1.2.4 Other
1.3 Applications of Prostate Cancer Diagnostics
1.3.1 age < 55
1.3.2 age 55-75
1.3.3 age > 75
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Prostate Cancer Diagnostics
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Prostate Cancer Diagnostics
2.3 Manufacturing Process Analysis of Prostate Cancer Diagnostics
2.4 Industry Chain Structure of Prostate Cancer Diagnostics
3 Technical Data and Manufacturing Plants Analysis of Prostate Cancer Diagnostics
3.1 Capacity and Commercial Production Date of Global Prostate Cancer Diagnostics Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Prostate Cancer Diagnostics Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Prostate Cancer Diagnostics Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Prostate Cancer Diagnostics Major Manufacturers in 2017
4 Global Prostate Cancer Diagnostics Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Prostate Cancer Diagnostics Capacity and Growth Rate Analysis
4.2.2 2017 Prostate Cancer Diagnostics Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Prostate Cancer Diagnostics Sales and Growth Rate Analysis
4.3.2 2017 Prostate Cancer Diagnostics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Prostate Cancer Diagnostics Sales Price
4.4.2 2017 Prostate Cancer Diagnostics Sales Price Analysis (Company Segment)
5 Prostate Cancer Diagnostics Regional Market Analysis
5.1 North America Prostate Cancer Diagnostics Market Analysis
5.1.1 North America Prostate Cancer Diagnostics Market Overview
5.1.2 North America 2013-2018E Prostate Cancer Diagnostics Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Prostate Cancer Diagnostics Sales Price Analysis
5.1.4 North America 2017 Prostate Cancer Diagnostics Market Share Analysis
5.2 Europe Prostate Cancer Diagnostics Market Analysis
5.2.1 Europe Prostate Cancer Diagnostics Market Overview
5.2.2 Europe 2013-2018E Prostate Cancer Diagnostics Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Prostate Cancer Diagnostics Sales Price Analysis
5.2.4 Europe 2017 Prostate Cancer Diagnostics Market Share Analysis
5.3 China Prostate Cancer Diagnostics Market Analysis
5.3.1 China Prostate Cancer Diagnostics Market Overview
5.3.2 China 2013-2018E Prostate Cancer Diagnostics Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Prostate Cancer Diagnostics Sales Price Analysis
5.3.4 China 2017 Prostate Cancer Diagnostics Market Share Analysis
5.4 Japan Prostate Cancer Diagnostics Market Analysis
5.4.1 Japan Prostate Cancer Diagnostics Market Overview
5.4.2 Japan 2013-2018E Prostate Cancer Diagnostics Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Prostate Cancer Diagnostics Sales Price Analysis
5.4.4 Japan 2017 Prostate Cancer Diagnostics Market Share Analysis
5.5 Southeast Asia Prostate Cancer Diagnostics Market Analysis
5.5.1 Southeast Asia Prostate Cancer Diagnostics Market Overview
5.5.2 Southeast Asia 2013-2018E Prostate Cancer Diagnostics Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Prostate Cancer Diagnostics Sales Price Analysis
5.5.4 Southeast Asia 2017 Prostate Cancer Diagnostics Market Share Analysis
5.6 India Prostate Cancer Diagnostics Market Analysis
5.6.1 India Prostate Cancer Diagnostics Market Overview
5.6.2 India 2013-2018E Prostate Cancer Diagnostics Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Prostate Cancer Diagnostics Sales Price Analysis
5.6.4 India 2017 Prostate Cancer Diagnostics Market Share Analysis
6 Global 2013-2018E Prostate Cancer Diagnostics Segment Market Analysis (by Type)
6.1 Global 2013-2018E Prostate Cancer Diagnostics Sales by Type
6.2 Different Types of Prostate Cancer Diagnostics Product Interview Price Analysis
6.3 Different Types of Prostate Cancer Diagnostics Product Driving Factors Analysis
6.3.1 Tumor Biomarker Tests Growth Driving Factor Analysis
6.3.2 Imaging Growth Driving Factor Analysis
6.3.3 Biopsy Growth Driving Factor Analysis
6.3.4 Other Growth Driving Factor Analysis
7 Global 2013-2018E Prostate Cancer Diagnostics Segment Market Analysis (by Application)
7.1 Global 2013-2018E Prostate Cancer Diagnostics Consumption by Application
7.2 Different Application of Prostate Cancer Diagnostics Product Interview Price Analysis
7.3 Different Application of Prostate Cancer Diagnostics Product Driving Factors Analysis
7.3.1 age < 55 of Prostate Cancer Diagnostics Growth Driving Factor Analysis
7.3.2 age 55-75 of Prostate Cancer Diagnostics Growth Driving Factor Analysis
7.3.3 age > 75 of Prostate Cancer Diagnostics Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Prostate Cancer Diagnostics
8.1 Genomic Health
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Genomic Health 2017 Prostate Cancer Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Genomic Health 2017 Prostate Cancer Diagnostics Business Region Distribution Analysis
8.2 Abbott
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Abbott 2017 Prostate Cancer Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Abbott 2017 Prostate Cancer Diagnostics Business Region Distribution Analysis
8.3 OPKO
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 OPKO 2017 Prostate Cancer Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 OPKO 2017 Prostate Cancer Diagnostics Business Region Distribution Analysis
8.4 Siemens Healthcare
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Siemens Healthcare 2017 Prostate Cancer Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Siemens Healthcare 2017 Prostate Cancer Diagnostics Business Region Distribution Analysis
8.5 DiaSorin
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 DiaSorin 2017 Prostate Cancer Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 DiaSorin 2017 Prostate Cancer Diagnostics Business Region Distribution Analysis
8.6 bioMeriux
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 bioMeriux 2017 Prostate Cancer Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 bioMeriux 2017 Prostate Cancer Diagnostics Business Region Distribution Analysis
8.7 Roche
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Roche 2017 Prostate Cancer Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Roche 2017 Prostate Cancer Diagnostics Business Region Distribution Analysis
8.8 MDx Health
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 MDx Health 2017 Prostate Cancer Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 MDx Health 2017 Prostate Cancer Diagnostics Business Region Distribution Analysis
8.9 Beckman Coulter
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Beckman Coulter 2017 Prostate Cancer Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Beckman Coulter 2017 Prostate Cancer Diagnostics Business Region Distribution Analysis
8.10 Myriad Genetics
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Myriad Genetics 2017 Prostate Cancer Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Myriad Genetics 2017 Prostate Cancer Diagnostics Business Region Distribution Analysis
8.11 Ambry Genetics
9 Development Trend of Analysis of Prostate Cancer Diagnostics Market
9.1 Global Prostate Cancer Diagnostics Market Trend Analysis
9.1.1 Global 2018-2025 Prostate Cancer Diagnostics Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Prostate Cancer Diagnostics Sales Price Forecast
9.2 Prostate Cancer Diagnostics Regional Market Trend
9.2.1 North America 2018-2025 Prostate Cancer Diagnostics Consumption Forecast
9.2.2 Europe 2018-2025 Prostate Cancer Diagnostics Consumption Forecast
9.2.3 China 2018-2025 Prostate Cancer Diagnostics Consumption Forecast
9.2.4 Japan 2018-2025 Prostate Cancer Diagnostics Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Prostate Cancer Diagnostics Consumption Forecast
9.2.6 India 2018-2025 Prostate Cancer Diagnostics Consumption Forecast
9.3 Prostate Cancer Diagnostics Market Trend (Product Type)
9.4 Prostate Cancer Diagnostics Market Trend (Application)
10 Prostate Cancer Diagnostics Marketing Type Analysis
10.1 Prostate Cancer Diagnostics Regional Marketing Type Analysis
10.2 Prostate Cancer Diagnostics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Prostate Cancer Diagnostics by Region
10.4 Prostate Cancer Diagnostics Supply Chain Analysis
11 Consumers Analysis of Prostate Cancer Diagnostics
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Prostate Cancer Diagnostics Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
Figure Picture of Prostate Cancer Diagnostics
Table Product Specifications of Prostate Cancer Diagnostics
Table Classification of Prostate Cancer Diagnostics
Figure Global Production Market Share of Prostate Cancer Diagnostics by Type in 2017
Figure Tumor Biomarker Tests Picture
Table Major Manufacturers of Tumor Biomarker Tests
Figure Imaging Picture
Table Major Manufacturers of Imaging
Figure Biopsy Picture
Table Major Manufacturers of Biopsy
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Prostate Cancer Diagnostics
Figure Global Consumption Volume Market Share of Prostate Cancer Diagnostics by Application in 2017
Figure age < 55 Examples
Table Major Consumers in age < 55
Figure age 55-75 Examples
Table Major Consumers in age 55-75
Figure age > 75 Examples
Table Major Consumers in age > 75
Figure Market Share of Prostate Cancer Diagnostics by Regions
Figure North America Prostate Cancer Diagnostics Market Size (Million USD) (2013-2025)
Figure Europe Prostate Cancer Diagnostics Market Size (Million USD) (2013-2025)
Figure China Prostate Cancer Diagnostics Market Size (Million USD) (2013-2025)
Figure Japan Prostate Cancer Diagnostics Market Size (Million USD) (2013-2025)
Figure Southeast Asia Prostate Cancer Diagnostics Market Size (Million USD) (2013-2025)
Figure India Prostate Cancer Diagnostics Market Size (Million USD) (2013-2025)
Table Prostate Cancer Diagnostics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Prostate Cancer Diagnostics in 2017
Figure Manufacturing Process Analysis of Prostate Cancer Diagnostics
Figure Industry Chain Structure of Prostate Cancer Diagnostics
Table Capacity and Commercial Production Date of Global Prostate Cancer Diagnostics Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Prostate Cancer Diagnostics Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Prostate Cancer Diagnostics Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Prostate Cancer Diagnostics Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Prostate Cancer Diagnostics 2013-2018E
Figure Global 2013-2018E Prostate Cancer Diagnostics Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Prostate Cancer Diagnostics Market Size (Value) and Growth Rate
Table 2013-2018E Global Prostate Cancer Diagnostics Capacity and Growth Rate
Table 2017 Global Prostate Cancer Diagnostics Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Prostate Cancer Diagnostics Sales (K Units) and Growth Rate
Table 2017 Global Prostate Cancer Diagnostics Sales (K Units) List (Company Segment)
Table 2013-2018E Global Prostate Cancer Diagnostics Sales Price (USD/Unit)
Table 2017 Global Prostate Cancer Diagnostics Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Prostate Cancer Diagnostics 2013-2018E
Figure North America 2013-2018E Prostate Cancer Diagnostics Sales Price (USD/Unit)
Figure North America 2017 Prostate Cancer Diagnostics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Prostate Cancer Diagnostics 2013-2018E
Figure Europe 2013-2018E Prostate Cancer Diagnostics Sales Price (USD/Unit)
Figure Europe 2017 Prostate Cancer Diagnostics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Prostate Cancer Diagnostics 2013-2018E
Figure China 2013-2018E Prostate Cancer Diagnostics Sales Price (USD/Unit)
Figure China 2017 Prostate Cancer Diagnostics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Prostate Cancer Diagnostics 2013-2018E
Figure Japan 2013-2018E Prostate Cancer Diagnostics Sales Price (USD/Unit)
Figure Japan 2017 Prostate Cancer Diagnostics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Prostate Cancer Diagnostics 2013-2018E
Figure Southeast Asia 2013-2018E Prostate Cancer Diagnostics Sales Price (USD/Unit)
Figure Southeast Asia 2017 Prostate Cancer Diagnostics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Prostate Cancer Diagnostics 2013-2018E
Figure India 2013-2018E Prostate Cancer Diagnostics Sales Price (USD/Unit)
Figure India 2017 Prostate Cancer Diagnostics Sales Market Share
Table Global 2013-2018E Prostate Cancer Diagnostics Sales (K Units) by Type
Table Different Types Prostate Cancer Diagnostics Product Interview Price
Table Global 2013-2018E Prostate Cancer Diagnostics Sales (K Units) by Application
Table Different Application Prostate Cancer Diagnostics Product Interview Price
Table Genomic Health Information List
Table Product Overview
Table 2017 Genomic Health Prostate Cancer Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Genomic Health Prostate Cancer Diagnostics Business Region Distribution
Table Abbott Information List
Table Product Overview
Table 2017 Abbott Prostate Cancer Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Abbott Prostate Cancer Diagnostics Business Region Distribution
Table OPKO Information List
Table Product Overview
Table 2017 OPKO Prostate Cancer Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 OPKO Prostate Cancer Diagnostics Business Region Distribution
Table Siemens Healthcare Information List
Table Product Overview
Table 2017 Siemens Healthcare Prostate Cancer Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Siemens Healthcare Prostate Cancer Diagnostics Business Region Distribution
Table DiaSorin Information List
Table Product Overview
Table 2017 DiaSorin Prostate Cancer Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 DiaSorin Prostate Cancer Diagnostics Business Region Distribution
Table bioMeriux Information List
Table Product Overview
Table 2017 bioMeriux Prostate Cancer Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 bioMeriux Prostate Cancer Diagnostics Business Region Distribution
Table Roche Information List
Table Product Overview
Table 2017 Roche Prostate Cancer Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Roche Prostate Cancer Diagnostics Business Region Distribution
Table MDx Health Information List
Table Product Overview
Table 2017 MDx Health Prostate Cancer Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 MDx Health Prostate Cancer Diagnostics Business Region Distribution
Table Beckman Coulter Information List
Table Product Overview
Table 2017 Beckman Coulter Prostate Cancer Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Beckman Coulter Prostate Cancer Diagnostics Business Region Distribution
Table Myriad Genetics Information List
Table Product Overview
Table 2017 Myriad Genetics Prostate Cancer Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Myriad Genetics Prostate Cancer Diagnostics Business Region Distribution
Table Ambry Genetics Information List
Figure Global 2018-2025 Prostate Cancer Diagnostics Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Prostate Cancer Diagnostics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Prostate Cancer Diagnostics Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Prostate Cancer Diagnostics Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Prostate Cancer Diagnostics Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Prostate Cancer Diagnostics Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Prostate Cancer Diagnostics Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Prostate Cancer Diagnostics Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Prostate Cancer Diagnostics Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Prostate Cancer Diagnostics by Type 2018-2025
Table Global Consumption Volume (K Units) of Prostate Cancer Diagnostics by Application 2018-2025
Table Traders or Distributors with Contact Information of Prostate Cancer Diagnostics by Region
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
